Cargando…

Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation

Since its first appearance in late 2019 in Wuhan, China, severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) has had a major impact on healthcare facilities around the world. Although in the past year, mass vaccination and the development of monoclonal antibody treatments have red...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaglione, Sara, Gotta, Franca, Vay, Daria, Leli, Christian, Roveta, Annalisa, Maconi, Antonio, Rocchetti, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277158/
https://www.ncbi.nlm.nih.gov/pubmed/37366528
http://dx.doi.org/10.1016/j.heliyon.2023.e17438
_version_ 1785060230851198976
author Scaglione, Sara
Gotta, Franca
Vay, Daria
Leli, Christian
Roveta, Annalisa
Maconi, Antonio
Rocchetti, Andrea
author_facet Scaglione, Sara
Gotta, Franca
Vay, Daria
Leli, Christian
Roveta, Annalisa
Maconi, Antonio
Rocchetti, Andrea
author_sort Scaglione, Sara
collection PubMed
description Since its first appearance in late 2019 in Wuhan, China, severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) has had a major impact on healthcare facilities around the world. Although in the past year, mass vaccination and the development of monoclonal antibody treatments have reduced the number of deaths and severe cases, the circulation of SARS-CoV-2 remains high. Over the past two years, diagnostics have played a crucial role in virus containment both in health care facilities and at the community level. For SARS-CoV-2 detection, the commonly used specimen type is the nasopharyngeal swab, although the virus can be identified in other matrices such as feces. Since fecal microbiota transplantation (FMT) assumes significant importance in the treatment of chronic gut infections and that feces may be a potential vehicle for transmission of SARS-CoV-2, in this study we have evaluated the performance of the rapid cartridge-based RT-PCR test STANDARD™ M10 SARS-CoV-2 (SD Biosensor Inc., Suwon, South Korea) using fecal samples. The results obtained indicates that STANDARD™ M10 SARS-CoV-2 can detect SARS-CoV-2 in stool samples even at low concentration. For this reason, STANDARD™ M10 SARS-CoV-2 could be used as reliable methods for the detection of SARS-CoV-2 in fecal samples and for the screening of FMT donors.
format Online
Article
Text
id pubmed-10277158
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102771582023-06-21 Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation Scaglione, Sara Gotta, Franca Vay, Daria Leli, Christian Roveta, Annalisa Maconi, Antonio Rocchetti, Andrea Heliyon Research Article Since its first appearance in late 2019 in Wuhan, China, severe acute respiratory syndrome caused by Coronavirus 2 (SARS-CoV-2) has had a major impact on healthcare facilities around the world. Although in the past year, mass vaccination and the development of monoclonal antibody treatments have reduced the number of deaths and severe cases, the circulation of SARS-CoV-2 remains high. Over the past two years, diagnostics have played a crucial role in virus containment both in health care facilities and at the community level. For SARS-CoV-2 detection, the commonly used specimen type is the nasopharyngeal swab, although the virus can be identified in other matrices such as feces. Since fecal microbiota transplantation (FMT) assumes significant importance in the treatment of chronic gut infections and that feces may be a potential vehicle for transmission of SARS-CoV-2, in this study we have evaluated the performance of the rapid cartridge-based RT-PCR test STANDARD™ M10 SARS-CoV-2 (SD Biosensor Inc., Suwon, South Korea) using fecal samples. The results obtained indicates that STANDARD™ M10 SARS-CoV-2 can detect SARS-CoV-2 in stool samples even at low concentration. For this reason, STANDARD™ M10 SARS-CoV-2 could be used as reliable methods for the detection of SARS-CoV-2 in fecal samples and for the screening of FMT donors. Elsevier 2023-06-18 /pmc/articles/PMC10277158/ /pubmed/37366528 http://dx.doi.org/10.1016/j.heliyon.2023.e17438 Text en © 2023 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Scaglione, Sara
Gotta, Franca
Vay, Daria
Leli, Christian
Roveta, Annalisa
Maconi, Antonio
Rocchetti, Andrea
Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
title Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
title_full Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
title_fullStr Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
title_full_unstemmed Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
title_short Rapid RT-PCR identification of SARS-CoV-2 in screening donors of fecal microbiota transplantation
title_sort rapid rt-pcr identification of sars-cov-2 in screening donors of fecal microbiota transplantation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277158/
https://www.ncbi.nlm.nih.gov/pubmed/37366528
http://dx.doi.org/10.1016/j.heliyon.2023.e17438
work_keys_str_mv AT scaglionesara rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation
AT gottafranca rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation
AT vaydaria rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation
AT lelichristian rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation
AT rovetaannalisa rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation
AT maconiantonio rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation
AT rocchettiandrea rapidrtpcridentificationofsarscov2inscreeningdonorsoffecalmicrobiotatransplantation